Advanced Drug Delivery Reviews

Editorial Board
pp. ii-ii(1)

Preface
pp. 1533-1537(5)

Amyloidosis and Alzheimer's disease
pp. 1539-1551(13)
Authors: Ghiso J.; Frangione B.

Vascular disorder in Alzheimer's disease: role in pathogenesis of dementia and therapeutic targets
pp. 1553-1559(7)
Author: Zlokovic B.V.

Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease
pp. 1561-1566(6)
Author: Small G.W.

Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales
pp. 1567-1577(11)
Authors: Tariot P.N.; Loy R.; Ryan J.M.; Porsteinsson A.; Ismail S.

-Secretase inhibitors and Alzheimer's disease
pp. 1579-1588(10)
Author: Roberts S.B.

-Secretase (BACE) as a drug target for alzheimer's disease
pp. 1589-1602(14)
Author: Vassar R.

A immunization and anti-A antibodies: potential therapies for the prevention and treatment of Alzheimer's disease
pp. 1603-1613(11)
Authors: Holtzman D.M.; Bales K.R.; Paul S.M.; DeMattos R.B.

Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
pp. 1615-1625(11)
Authors: Stern D.; Du Yan S.; Fang Yan S.; Marie Schmidt A.

Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease
pp. 1627-1656(30)
Authors: Moore A.H.; O'Banion M.K.